News
Brief news reports on Tuberculosis
By
Desmond Tutu
Published: Nov. 7, 2012, 8:50 p.m.·
Tags:
None
Leaders of southern African nations are meeting in Mozambique this week to plan an unprecedented attack on an ancient foe: tuberculosis. Fueled by new drug-resistant strains and the HIV/AIDS pandemic, TB is spreading like wildfire through South Africa's mines and to the world beyond.
Read More →
By
Veredus Laboratories
Published: Nov. 7, 2012, 8:37 p.m.·
Tags:
None
Veredus Laboratories has launched VereMTBTM, a multiplexed molecular diagnostic chip capable of fast and accurate detection of Mycobacterium Tuberculosis Complex (MTBC) and its mutations, as well as 9 other clinically relevant non-tubercular mycobacterium. These mutations are responsible for resistance to multiple drugs and are reinvigorating the global spread of Tuberculosis.
Read More →
By
OPKO Health, Inc.
Published: Nov. 7, 2012, 8:26 p.m.·
Tags:
None
OPKO Health, Inc. (NYSE: OPK) announced today that it was awarded a $1 million grant from the Bill & Melinda Gates Foundation to support the development of a diagnostic test to distinguish between latent tuberculosis and active tuberculosis utilizing OPKO's proprietary molecular diagnostics technology. Utilizing its proprietary technology, OPKO is developing simple blood tests to identify biomarkers for a wide variety of diseases, including neurodegenerative disorders and various malignancies.
Read More →
By
UCAB
Published: Nov. 6, 2012, 11:30 p.m.·
Tags:
None
During the last UCAB meeting on 29-31 October, 2012, main priorities for the next year were defined, and work undertaken over the last 2 years (since establishment) was summarized.
Read More →
Published: Nov. 6, 2012, 10:58 p.m.·
Tags:
None
4th Union Asia Pacific Region Conference on Lung Health, Melia hotel, Hanoi, Vietnam, 10-13 April 2013
Read More →
By
PlusNews
Published: Nov. 6, 2012, 9:42 p.m.·
Tags:
None
South Africa grants almost every patent application it receives, making its patent regime one of the world’s most lenient. While pharmaceutical companies cash in, patients face staggering healthcare costs, and medicines like cancer treatments, third-line antiretrovirals (ARVs) and treatments for drug-resistant tuberculosis (DR-TB) are often priced out of reach.
Read More →
By
Kaiser Daily Global Health Policy Report
Published: Nov. 5, 2012, 10:20 p.m.·
Tags:
None
The November 2012 issue of USAID's "Global Health News" newsletter focuses on tuberculosis (TB). The newsletter features a link to a video titled "Voices of TB," an infographic (.pdf) on innovations in TB diagnostics, and links to an IMPACTblog piece and a USAID press release discussing TB diagnostics (November 2012).
Read More →
By
The Korea Herald
Published: Nov. 5, 2012, 9:31 p.m.·
Tags:
None
North Korea is being plagued by a widespread and difficult strain of tuberculosis and needs urgent measures to curb it, the chairman of a South Korean aid group said Monday.
Read More →
By
Catherine Saez
Published: Nov. 3, 2012, 2:39 p.m.·
Tags:
None
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) held its 26th assembly this week and elected its new president. He presented the future orientation of the industry group, saying will work on trust-building and needs predictability in the regulatory process, policies that sustain and encourage innovation, and a strong intellectual property system, he said.
Read More →
By
Radboud University Nijmegen
Published: Nov. 3, 2012, 2:32 p.m.·
Tags:
None
Researchers from the Radboud UMC have conducted the first study globally to show that intensified antibiotic treatment can improve the prognosis of patients with tuberculous (TB) meningitis, the most severe form of TB which carries a mortality of up to 50%. Their results are published in the highest-ranking infectious disease journal, Lancet Infectious Diseases.
Read More →
Page 778 of 878 · Total posts: 10
←First
777
778
779
Last→